SEC Form 3 · accession 0001493152-18-015806
Eton Pharmaceuticals, Inc. · ETON
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Imprimis Pharmaceuticals, Inc.
10% Owner
Period of report
Nov 9, 2018
Accepted (ET)
Nov 13, 2018 · 5:41 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001710340
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 3,500,000 | D |
Table II — derivative securities
No Table II lines on this filing.